Solutia, Inc.’s subsidiary, Solutia Europe SA/NV (SESA), has reached a definitive agreement to sell its Pharmaceutical Services business, comprised of CarboGen AG and AMCIS AG. Under the terms of the agreement, Dishman Pharmaceuticals & Chemicals, Ltd. will purchase 100% of the stock of CarboGen and AMCIS, as well as certain other assets used in the Pharmaceutical Services business, for $74.5 million. This transaction is subject to removal of the restrictions related to the sale under ...